Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Business Bites: Biomet's knee growth still slowing; Exact gets reimbursement boost

This article was originally published in Clinica

Executive Summary

Biomet saw sales increase 6% year-on-year during its first quarter, with its hip and knee franchises both growing 4%. But although this might appear a decent performance on the surface, it may disappoint observers who had hoped to see a turnaround in the stagnant large joint reconstructive market. Expectations were raised in Q3, when Biomet’s knee implant sales increased 8% (or 9% at constant currency rates), but then scotched in Q4 when growth in the division fell to 5%. The latest results won’t do much to encourage other players that the sector is back on the up.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT101994

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel